Chinese Journal of Antituberculosis ›› 2026, Vol. 48 ›› Issue (1): 41-48.doi: 10.19982/j.issn.1000-6621.20250353
• Original Articles • Previous Articles Next Articles
Huang Shanshan1, Dong Xiaowei2, Zhou Fangjing2, Feng Huiying3, Li Jianwei2, Chen Yuhui1(
)
Received:2025-09-01
Online:2026-01-10
Published:2025-12-31
Contact:
Chen Yuhui
E-mail:pistachia@163.com
Supported by:CLC Number:
Huang Shanshan, Dong Xiaowei, Zhou Fangjing, Feng Huiying, Li Jianwei, Chen Yuhui. Analysis of epidemiological characteristics and influencing factors of pulmonary tuberculosis recurrence in Guangdong Province[J]. Chinese Journal of Antituberculosis, 2026, 48(1): 41-48. doi: 10.19982/j.issn.1000-6621.20250353
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.19982/j.issn.1000-6621.20250353
| 特征 | 合计(53047例) | 非复发(51630例) | 复发(1417例) | Wald Z值 | P值 | HR(95%CI)值 | |||
|---|---|---|---|---|---|---|---|---|---|
| 例数 | 构成比 (%) | 例数 | 构成比 (%) | 例数 | 构成比 (%) | ||||
| 性别 | |||||||||
| 女性 | 14736 | 27.78 | 14463 | 98.15 | 273 | 1.85 | 1.000 | ||
| 男性 | 38311 | 72.22 | 37167 | 97.01 | 1144 | 2.99 | 7.123 | <0.001 | 1.617(1.417~1.846) |
| 年龄组(岁) | |||||||||
| 0~19 | 2865 | 5.40 | 2817 | 98.32 | 48 | 1.68 | 1.000 | ||
| 20~39 | 19841 | 37.40 | 19543 | 98.50 | 298 | 1.50 | -0.580 | 0.562 | 0.913(0.671~1.242) |
| 40~59 | 17473 | 32.94 | 16853 | 96.45 | 620 | 3.55 | 5.121 | <0.001 | 2.171(1.613~2.920) |
| 60~79 | 11578 | 21.83 | 11157 | 96.36 | 421 | 3.64 | 5.263 | <0.001 | 2.247(1.662~3.037) |
| 80~103 | 1290 | 2.43 | 1260 | 97.67 | 30 | 2.33 | 1.527 | 0.127 | 1.429(0.904~2.259) |
| 民族 | |||||||||
| 汉族 | 51676 | 97.42 | 50278 | 97.29 | 1398 | 2.71 | 1.000 | ||
| 少数民族或其他 | 1371 | 2.58 | 1352 | 98.61 | 19 | 1.39 | -3.054 | 0.002 | 0.485(0.304~0.771) |
| 职业 | |||||||||
| 办公室职员 | 1490 | 2.81 | 1467 | 98.46 | 23 | 1.54 | 1.000 | ||
| 工业工人 | 7323 | 13.81 | 7212 | 98.48 | 111 | 1.52 | 0.090 | 0.928 | 1.021(0.646~1.613) |
| 农牧民 | 20795 | 39.20 | 20022 | 96.28 | 773 | 3.72 | 4.259 | <0.001 | 2.511(1.644~3.837) |
| 家务劳动或失业 | 11898 | 22.43 | 11633 | 97.77 | 265 | 2.23 | 1.806 | 0.071 | 1.493(0.966~2.307) |
| 商业职员 | 2207 | 4.16 | 2167 | 98.19 | 40 | 1.81 | 0.774 | 0.439 | 1.228(0.730~2.066) |
| 青少年 | 2024 | 3.82 | 2003 | 98.96 | 21 | 1.04 | -1.199 | 0.230 | 0.694(0.381~1.261) |
| 退休 | 2004 | 3.78 | 1946 | 97.11 | 58 | 2.89 | 2.711 | 0.007 | 1.971(1.207~3.221) |
| 其他职业 | 5306 | 10.00 | 5180 | 97.63 | 126 | 2.37 | 1.985 | 0.047 | 1.583(1.006~2.492) |
| 是否患糖尿病 | |||||||||
| 否 | 51414 | 96.92 | 50079 | 97.40 | 1335 | 2.60 | 1.000 | ||
| 是 | 1625 | 3.06 | 1544 | 95.02 | 81 | 4.98 | 5.915 | <0.001 | 1.968(1.572~2.463) |
| 未知a | 8 | 0.02 | 7 | 7/8 | 1 | 1/8 | - | - | |
| 患者来源 | |||||||||
| 主动发现 | 1338 | 2.52 | 1325 | 99.03 | 13 | 0.97 | 1.000 | ||
| 被动发现或其他 | 51709 | 97.48 | 50305 | 97.28 | 1404 | 2.72 | 3.719 | <0.001 | 2.819(1.633~4.867) |
| 发现延迟 | |||||||||
| 否 | 25459 | 47.99 | 24878 | 97.72 | 581 | 2.28 | 1.000 | ||
| 是 | 27588 | 52.01 | 26752 | 96.97 | 836 | 3.03 | 5.428 | <0.001 | 1.342(1.207~1.493) |
| 诊断结果 | |||||||||
| 病原学阴性 | 34034 | 64.158 | 33369 | 98.05 | 665 | 1.95 | 1.000 | ||
| 病原学阳性 | 18878 | 35.59 | 18130 | 96.04 | 748 | 3.96 | 13.668 | <0.001 | 2.077(1.871~2.307) |
| 无结果 | 135 | 0.25 | 131 | 97.04 | 4 | 2.96 | 0.906 | 0.365 | 1.575(0.590~4.210) |
| 是否使用FDC | |||||||||
| 否 | 15771 | 29.73 | 15280 | 96.89 | 491 | 3.11 | 1.000 | ||
| 是 | 37276 | 70.27 | 36350 | 97.52 | 926 | 2.48 | -4.295 | <0.001 | 0.786(0.705~0.878) |
| 管理地区 | |||||||||
| 非珠三角 | 23516 | 44.33 | 22690 | 96.49 | 826 | 3.51 | 1.000 | ||
| 珠三角 | 29531 | 55.67 | 28940 | 98.00 | 591 | 2.00 | -10.495 | <0.001 | 0.567(0.510~0.630) |
| 随访年限 | 基线总 患者例数 | 风险集 患者例数 | 累计复发 患者例数 | 粗复发率 (%) | 累计复发率 (%,95%CI) | 总随访时间 (人年) | 复发密度 (/100人年) |
|---|---|---|---|---|---|---|---|
| 1年 | 53047 | 52640 | 407 | 0.77 | 0.77(0.69~0.84) | 52868.60 | 0.77 |
| 2年 | 53047 | 52303 | 744 | 1.40 | 1.40(1.30~1.50) | 105314.84 | 0.71 |
| 3年 | 53047 | 52058 | 988 | 1.86 | 1.86(1.75~1.98) | 157491.49 | 0.63 |
| 4年 | 53047 | 51842 | 1202 | 2.27 | 2.27(2.14~2.39) | 209441.09 | 0.57 |
| 5年 | 53047 | 48092 | 1359 | 2.56 | 2.57(2.43~2.70) | 260567.73 | 0.52 |
| 研究期末 | 53047 | - | 1417 | 2.67 | 2.83(2.66~3.00) | 283429.25 | 0.50 |
| 变量 | β值 | s | Wald χ2值 | P值 | aHR(95%CI)值 |
|---|---|---|---|---|---|
| 男性 | 0.322 | 0.068 | 22.100 | <0.001 | 1.380(1.207~1.578) |
| 农牧民 | 0.462 | 0.221 | 4.360 | 0.037 | 1.587(1.029~2.450) |
| 合并糖尿病 | 0.252 | 0.116 | 4.700 | 0.030 | 1.287(1.024~1.616) |
| 被动发现 | 0.552 | 0.280 | 3.890 | 0.049 | 1.738(1.003~3.009) |
| 发现延迟 | 0.133 | 0.055 | 5.840 | 0.016 | 1.142(1.025~1.271) |
| 病原学阳性 | 0.742 | 0.055 | 184.000 | <0.001 | 2.099(1.886~2.337) |
| 使用FDC | -0.220 | 0.057 | 14.900 | <0.001 | 0.802(0.717~0.897) |
| 管理地区为珠三角 | -0.408 | 0.065 | 39.700 | <0.001 | 0.665(0.585~0.755) |
| [1] | 周芳静, 吴惠忠, 李建伟, 等. 广东省2016—2020年肺结核流行特征分析. 中华流行病学杂志, 2022, 43(10): 1568-1574. doi:10.3760/cma.j.cn112338-20220121-00059. |
| [2] |
Mirsaeidi M, Sadikot RT. Patients at high risk of tuberculosis recurrence (Review). Int J Mycobacteriol, 2018, 7(1): 1-6. doi:10.4103/ijmy.ijmy_164_17.
pmid: 29516879 |
| [3] | World Health Organization. Global tuberculosis report 2023. Geneva: World Health Organization, 2023. |
| [4] | World Health Organization. Definitions and reporting framework for tuberculosis—2013 revision. Geneva: World Health Organization, 2013. |
| [5] | 张红伟, 陈曦, 孙闪华, 等. 北京市初治肺结核患者治疗成功后复发情况及危险因素分析. 疾病监测, 2021, 36(8): 818-823. doi:10.3784/jbjc.202106110332. |
| [6] | 周芳静, 冯慧莹, 方兰君, 等. 2016—2020年广东省活动性肺结核患者发现延迟的变化趋势及影响因素分析. 中国防痨杂志, 2023, 45(1):85-95. doi:10.19982/j.issn.1000-6621.20220389. |
| [7] | 李涛, 赵雁林, 贾忠伟. 结核病复发及其影响因素研究进展. 疾病监测, 2024, 39(4):403-411. doi:10.3784/jbjc.202311140598. |
| [8] | Li T, Zhang B, Du X, et al. Recurrent Pulmonary Tuberculosis in China, 2005 to 2021. JAMA Netw Open, 2024, 7(8): e2427266. doi:10.1001/jamanetworkopen.2024.27266. |
| [9] | 王荣, 许可, 洪忻, 等. 南京市初治肺结核患者成功治疗后复发及影响因素分析. 中国热带医学, 2022, 22(8): 735-738. doi:10.13604/j.cnki.46-1064/r.2022.08.09. |
| [10] | 李京, 高媛, 逯嘉, 等. 四川省肺结核患者2年内复发情况及影响因素分析. 中国防痨杂志, 2023, 45(11): 1038-1044. doi:10.19982/j.issn.1000-6621.20230193. |
| [11] | 高丽, 庞学文, 张国钦, 等. 天津市初治活动性肺结核患者成功治疗后2年内复发的危险因素分析. 中国防痨杂志, 2022, 44(7): 698-703. doi:10.19982/j.issn.1000-6621.20220017. |
| [12] | Ruan Q, Yang Q, Sun F, et al. Recurrent pulmonary tuberculosis after treatment success: a population-based retrospective study in China. Clin Microbiol Infect, 2022, 28(5): 684-689. doi:10.1016/j.cmi.2021.09.022. |
| [13] |
Wang Y, Shi J, Yin X, et al. The impact of diabetes mellitus on tuberculosis recurrence in Eastern China: a retrospective cohort study. BMC Public Health, 2024, 24(1): 2534. doi:10.1186/s12889-024-20019-5.
pmid: 39294658 |
| [14] | 地尔木拉提·吐孙, 麦维兰江·阿不力米提, 刘振江, 等. 2011—2020年新疆喀什地区初治肺结核患者复发影响因素分析. 中国防痨杂志, 2021, 43(11): 1176-1182. doi:10.3969/j.issn.1000-6621.2021.11.013. |
| [15] | 孙晴, 王小平, 符剑, 等. 2013—2020年江苏省南通市初治结核病患者成功治疗后复发情况及其影响因素分析. 疾病监测, 2024, 39(10): 1270-1275. doi:10.3784/jbjc.202403130161. |
| [16] | Li S, Meng L, Chiolero A, et al. Trends in smoking prevalence and attributable mortality in China, 1991—2011. Prev Med, 2016, 93:82-87. doi:10.1016/j.ypmed.2016.09.027. |
| [17] | 严天心, 马文斌, 王嘉, 等. 2010—2023年中国肺结核合并症患者治疗依从性及治疗结局影响因素分析. 中国防痨杂志, 2025, 47(10): 1268-1278. doi:10.19982/j.issn.1000-6621.20250237. |
| [18] |
Feng Y, Kong Y, Barnes PF, et al. Exposure to cigarette smoke inhibits the pulmonary T-cell response to influenza virus and Mycobacterium tuberculosis. Infect Immun, 2011, 79(1):229-237. doi:10.1128/IAI.00709-10.
pmid: 20974820 |
| [19] | Mujtaba MA, Richardson M, Shahzad H, et al. Demographic and Clinical Determinants of Tuberculosis and TB Recurrence: A Double-Edged Retrospective Study from Pakistan. J Trop Med, 2022:4408306. doi:10.1155/2022/4408306. |
| [20] | Kundu J, Verma A, Verma I, et al. Molecular mechanism of interaction of Mycobacterium tuberculosis with host macrophages under high glucose conditions. Biochem Biophys Rep, 2021, 26: 100997. doi:10.1016/j.bbrep.2021.100997. |
| [21] |
Baker MA, Harries AD, Jeon CY, et al. The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Med, 2011, 9: 81. doi:10.1186/1741-7015-9-81.
pmid: 21722362 |
| [22] | 雷蓉蓉, 汪清雅, 张婷. 重庆市肺结核患者复发情况及影响因素分析. 中国热带医学, 2020, 20(11): 1092-1095. doi:10.13604/j.cnki.46-1064/r.2020.11.16. |
| [23] | 许卫国, 高瞻, 范本达. 短程化疗结束后痰菌阴性肺结核患者复发情况随访观察. 中华结核和呼吸杂志, 2003, 26(2): 13-15. doi:10.3760/j:issn:1001-0939.2003.02.004. |
| [24] |
Cudahy PGT, Wilson D, Cohen T. Risk factors for recurrent tuberculosis after successful treatment in a high burden setting: a cohort study. BMC Infect Dis, 2020, 20(1):789. doi:10.1186/s12879-020-05515-4.
pmid: 33097000 |
| [25] | 买日哈巴·卡米力, 买吾拉江·依马木, 阿丽米热·阿不力米提, 等. 2013—2020年新疆喀什地区结核病患者复发的空间聚集性及影响因素分析. 现代预防医学, 2024, 51(14): 2501-2506. doi:10.20043/j.cnki.MPM.202404155. |
| [26] | 杜芳芳, 成诗明, 王倪, 等. 抗结核固定剂量复合剂全疗程使用的影响因素分析. 中国防痨杂志, 2024, 46(7): 792-798. doi:10.19982/j.issn.1000-6621.20240172. |
| [27] | 王倪, 黄飞, 竺丽梅, 等. 提高抗结核药品固定剂量复合剂在省市级结核病定点医院推广使用的实施性研究. 中国防痨杂志, 2022, 44(9): 927-933. doi:10.19982/j.issn.1000-6621.20220145. |
| [28] | 国家卫生健康委员会办公厅. 国家卫生健康委办公厅关于印发中国结核病预防控制工作技术规范(2020年版)的通知. 国卫办疾控〔2020〕279号. 2020-04-02. |
| [29] | 周林, 陆宇. 抗结核药品固定剂量复合制剂的临床使用专家共识. 中国防痨杂志, 2020, 42(9): 885-893. doi:10.3969/j.issn.1000-6621.2020.09.001. |
| [30] | Long Q, Guo L, Jiang W, et al. Ending tuberculosis in China: health system challenges. Lancet Public Health, 2021, 6(12): e948-e953. doi:10.1016/S2468-2667(21)00203-6. |
| [1] | Lei Hui, Zhang Shu, Li Ting, Gao Yuan, Liu Shuang, Chen Chuang, Xia Lan, Wang Weina, Gao Wenfeng, He Jinge. Analysis of infection patterns and drug resistance of 22 recurrent pulmonary tuberculosis patients in Sichuan based on whole-genome sequencing [J]. Chinese Journal of Antituberculosis, 2024, 46(6): 641-647. |
| [2] | Yang Jieying, Xiao Xincai, Du Yuhua, Lai Keng, He Liqian, Wang Ting, Lin Ying, He Weiyun. Analysis of epidemiological characteristics and therapeutic prognosis among pulmonary tuberculosis patients complicated with diabetes mellitus in Guangzhou City from 2014 to 2023 [J]. Chinese Journal of Antituberculosis, 2024, 46(12): 1504-1510. |
| [3] | Yang Chao, Wang Jing, Tang Guilin, Geng Yang. Analysis of epidemiological characteristics and treatment outcomes of pulmonary tuberculosis patients in floating population in Tongzhou District of Beijing, 2012—2021 [J]. Chinese Journal of Antituberculosis, 2023, 45(6): 594-600. |
| [4] | Li Jing, Gao Yuan, Lu Jia, He Jinge, Chen Chuang, Zhong Yin, Yang Ni, Xia Lan. Analysis of recurrence and influencing factors of tuberculosis patients in Sichuan Province within 2 years [J]. Chinese Journal of Antituberculosis, 2023, 45(11): 1038-1044. |
| [5] | ZHONG Qian-hong, MA Xiao-hui, ZHONG Yong-hui, ZHAO Zhi-meng, ZHANG Xi-lin, XU Bang, LUO Jie-ying, ZHONG Li-ping, DAI Lei. Analysis of recurrence rate of pulmonary tuberculosis patients in Foshan and the influencing factors from 2014 to 2018 [J]. Chinese Journal of Antituberculosis, 2022, 44(7): 690-697. |
| [6] | GAO Li, PANG Xue-wen, ZHANG Guo-qin, LI Jing-xin, ZHANG Fan. Analysis of risk factors for recurrence within 2 years after successful treatment of newly treated active pulmonary tuberculosis in Tianjin [J]. Chinese Journal of Antituberculosis, 2022, 44(7): 698-703. |
| [7] | Muradil·Mardan , Parhat·Yasin , Xu Tao, Cai Xiaoyu, Yakup·Abliz , Xun Chuanhui, Sheng Weibin, Mardan·Mamat . Meta-analysis of operation combined with irrigation and drainage of focus lesion in the treatment of spinal tuberculosis [J]. Chinese Journal of Antituberculosis, 2022, 44(12): 1314-1320. |
| [8] | Maiweilanjiang·Abulimiti , Diermulati·Tusun , Keyoumu·Wubulikasimu , Musa·Aihaiti , Liu Zhenjiang, Li Bin, Xirizhati·Mamuti , Chen Jinou, Li Tao, Su Wei, Zhao Yanlin, Ou Xichao. Analysis of influencing factors of recurrence after successful treatment in new pulmonary tuberculosis patients in Kashgar Prefecture, Xinjiang Uygur Autonomous Region [J]. Chinese Journal of Antituberculosis, 2022, 44(11): 1148-1153. |
| [9] | Yang Xiaoyu, Qiu Lei, Zhang Shunxian, Zhang Shaoyan, Zhou Wei, Wu Xianwei, Wu Dingzhong, Zhang Huiyong, Xiao Heping, Lu Zhenhui. Analysis of influencing factors of recurrence in cured patients with multidrug-resistant pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2022, 44(10): 1028-1036. |
| [10] | ZHANG Li-jie*, HAN Xi-qin, WANG Jing-ping, CHEN Yu-hui, CHEN Sheng-yu, CHEN Ling, LI Bo, LIN Ming-gui, LI You-lun, SHI Lian, XI Xiu-e, MA Li-ping, WANG Xin, WANG Fei, ZHAO Cai-yan, WANG Fu-rong, CHEN Sen-lin, WU Xiang, LI Po, ZHANG Peng, LENG Xue-yan, ZHANG Hai-qing, CAO Wen-li, SHU Wei, SUN Yu-xian, XIE Shi-heng, TIAN Xi-zhong, HUANG Xue-rui, DU Jian, GAO Wei-wei. The relationship between bacterial load and treatment failure and recurrence of sputum positive retreatment pulmonary tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2021, 43(4): 335-340. |
| [11] | Diermulati ·Tusun, Maiweilanjiang ·Abulimiti, LIU Zhen-jiang, Xirizhati ·Mamuti, LI Guan-zhen, LI Tao, CHEN Jin-ou, Liwayiding ·Aersila, ZHAO Yan-lin, ZHANG Li-jie, OU Xi-chao. Analysis of influencing factors of tuberculosis recurrence among primary treated pulmonary tuberculosis patients in Kashgar, Xinjiang [J]. Chinese Journal of Antituberculosis, 2021, 43(11): 1176-1182. |
| [12] | Jian DU,Xi-qin HAN,Wei SHU,Zi CHEN,Shi-heng XIE,Xiao-ya LYU,Qi-ping GE,Yan MA,Yu-hong LIU,Liang LI,Wei-wei GAO. Analysis of risk factors for recurrence of pulmonary tuberculosis after successful completion of treatment of relapsed smear positive tuberculosis [J]. Chinese Journal of Antituberculosis, 2019, 41(6): 624-631. |
| [13] | Xin ZHONG,Qiang ZHANG,Zu-yuan XU,De-jian. FANG. Efficacy of anterior revision on failure in patients with thoracolumbar tuberculosis underwent posterior fixation [J]. Chinese Journal of Antituberculosis, 2019, 41(5): 521-528. |
| [14] | Da-wei LI,Juan QIAO,Guo-ke TANG,Yuan-zheng MA. Characteristics and effects of surgical treatment for thoracolumbar tuberculosis after vertebral augmentation [J]. Chinese Journal of Antituberculosis, 2019, 41(4): 383-388. |
| [15] | Li-ming YAO,Chen-guang JIA,Zhuo LI,Zhao-liang DONG,lian-bo WANG,Feng-sheng LIU. Clinical study on the reasons and therapeutic scheme of postoperative recurrence of spinal tuberculosis in lumbosacral portion [J]. Chinese Journal of Antituberculosis, 2019, 41(4): 405-413. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
京公网安备11010202007215号
Total visitors: Visitors of today: Now online:
This work is licensed under Creative Commons Attribution 3.0 License.